70 likes | 322 Views
The overall patient monitoring devices market was valued as $17.0 billion in 2013 and is poised to grow at a CAGR of 5.5% till 2018. The market is driven by rise in the geriatric population, growing incidences of lifestyle diseases, increased use of home and remote monitors, and technological advancements like portability of equipment.
E N D
MarketsandMarkets Presents Patient Monitoring Devices Market worth $22.2 Billion by 2018 http://www.marketsandmarkets.com/Market-Reports/patient-healthcare-monitoring-systems-devices-market-678.html
The “Patient Monitoring Device/ Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Multiparameter, Remote, Weight, Temperature), End-user (Hospitals, Home) - Global Forecast to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global patient monitoring devices market along with the estimates and forecasts of the revenue and share analysis. Browse: 234 market data tables 47 figures in-depth TOC on “Patient Monitoring Devices Market ” http://www.marketsandmarkets.com/Market-Reports/patient-healthcare-monitoring-systems-devices-market-678.html Early buyers will receive 10% customization of reports.
The global patient monitoring devices market will reach $22,173.8 million by 2018 growing at a CAGR of 5.5% during the forecast period (2013–2018). The global patient monitoring devices market is segregated into nine main segments, namely, hemodynamic, neurology, cardiac, respiratory, fetal and neonatal, multiparameter, remote patient monitors, temperature, and weight management monitors. The driving factors of the patient monitoring market include growing population size of the elderly, rising incidences of unhealthy lifestyle, and technological developments like portability of equipment. The cardiac monitors segment had the largest share in 2013 of the total patient monitoring devices market, whereas neuromonitoring devices segment will be the fastest growing segment by 2018.
The respiratory monitors segment is also expected to grow at a high pace in the forecasted period. This growth can be attributed to the rising incidences of obstructive sleep apnea and the rising alternate uses of capnographs. The remote patient monitoring (RPM) devices segment is expected to grow at a fast pace majorly driven by government regulations to control the rising healthcare costs. The technological innovations and developments of products are contributing to the market growth of RPM devices. The cardiac monitors segment is further sub divided into ECG, event monitors, and cardiac output sub segments. ECG was the leading segment owing to expanding old population and growing incidences of cardiac and diseases such as diabetes and hypertension.
North America accounted for the highest share in 2013 and is poised to grow from 2013 to 2018. The major growth factors contributing to the growth of the North America market are the aging population and lifestyle diseases that are further adding to the overall prevalence of chronic diseases. Europe was the second leading contributor to the patient monitoring devices market in 2013. However, the growth of this region is expected to be sluggish in the forecast period and is estimated to grow at a lower CAGR, due to factors such as uneven reimbursement policies, declining birth rates, and reduced number of beds in hospitals. APAC is the most promising region for patient monitoring devices in the coming five years. It is expected to grow at a higher CAGR over the forecast period.
High population base and improved purchasing power of patients will be the major drivers of this market. Moreover, the economic instability in the western countries enables the companies to focus on the APAC region in order to meet their revenue targets. The key players in the patient monitoring devices market are Abbott Laboratories (U.S), Covidien (Ireland), Drager Medical GmbH (Germany), GE Healthcare (U.K.), Johnson & Johnson Inc. (U.S), Masimo Corporation (U.S), Mindray Medical (China), Mortara Instrument Inc. (U.S.), Natus (U.S.), Nihon Kohden (Japan), Nonin Medical (U.S), Omron Healthcare (Japan), Philips Healthcare (Netherlands), Roche Diagnostics Limited (Switzerland) and Welch Allyn (U.S.).
About Marketsandmarkets : MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact us : Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252Tel: +1-888-6006-441 sales@marketsandmarkets.com